Skip to main content

FDA Updates

Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer

Keytruda plus Chemotherapy FDA Approved for First-Line Treatment of Cervical Cancer

Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer

Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical Cancer

Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

Welireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau Disease

Rezurock Novel Oral Therapy FDA Approved for Chronic Graft-Versus-Host Disease

Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease

Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer

Page 10 of 34
Results 91 - 100 of 331